Healthcare & Life Sciences Industry Updates

Google News – Pharmaceuticals External News

Rocket Pharmaceuticals CEO Gaurav Shah sells $7,752 in shares - Investing.com

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

Recursion Pharmaceuticals Stock Climbs 13% As AI Drug Pipeline Progress And Spending Cuts Boost Sentiment - TIKR.com

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

Eton Pharmaceuticals CEO Sean Brynjelsen sells $6.08m in stock - Investing.com

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

Agios Pharmaceuticals: Indication Stacking Is Creating A Commercial Flywheel (NASDAQ:AGIO) - Seeking Alpha

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

Teva scores rare partial win in CMS price negotiation appeal - Fierce Pharma

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

Vertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still Ahead - The Motley Fool

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

Amylyx Pharmaceuticals Announces Pricing of an Upsized $500 Million Underwritten Public Offering of Common Stock - Business Wire

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

Celon Pharma's generic semaglutide drug matches Ozempic in early study, shares jump - Reuters

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

How Investors Are Reacting To Aurinia Pharmaceuticals (AUPH) Extended Voclosporin Exclusivity And Share Buyback - Yahoo Finance

news.google.com · 21 Aug 2026

Google News – Biopharma External News

Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market - Corsicana Daily Sun

news.google.com · 21 Aug 2026

Google News – Biopharma External News

FDA Approves ENNUMO™ (pegfilgrastim-pccg), Accord BioPharma's Second Pegfilgrastim Biosimilar to NEULASTA® (pegfilgrastim) - PR Newswire

news.google.com · 21 Aug 2026

Google News – Biopharma External News

Quantum BioPharma Stock Gains 6.7% on FDA Clearance for Lucid-MS Phase 2 Trial - kalkine.ca

news.google.com · 21 Aug 2026

Google News – Biopharma External News

China A-Shares Close Higher Across All Four Major Indexes; Biopharma Sector Surges as Over 4,100 Stocks Gain - finance.biggo.com

news.google.com · 21 Aug 2026

Google News – Biopharma External News

Manor College president named to biopharmaceutical company’s board of directors - Glenside Local

news.google.com · 21 Aug 2026

Google News – Biopharma External News

Ingenia Therapeutics Debuts on KOSDAQ to Accelerate Next-Gen Vascular Antibody Pipeline - BioPharma APAC

news.google.com · 21 Aug 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Why healthcare providers are sidelining employees amid coronavirus pandemic

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

Technology transforms health human resources management - hospitalnews.com

SPARSH Hospitals Appoints Kalappa K.B. as Group Chief Human Resources Officer - hrtoday.in

UK wasted £10bn on PPE that left NHS staff poorly protected, Covid inquiry finds

Early Alert: Portrait Core Services Software Issue from GE HealthCare

Skilled labor demand is exploding. AI may be both a cause and a solution

Women are significantly underrepresented in the AI workforce

How can wearables be used in clinical trials? FDA outlines best practices

Siemens Healthineers, Philips awarded ARPA-H funds for stroke robots

Cyberattacks have plagued the medtech industry in 2026

BBC Inside Science

Vapes could lead to health harms in children, doctors warn

Optimal Balance Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels

Gap between demand and hiring widens

Vitestro secures FDA nod for robotic blood draw device

B. Braun Medical Inc. Issues Voluntary North American Recall of Excel® Lactated Ringers Injection, 1000mL Due to the Presence of Particulate Matter

Vaccine breakthrough stops cancer returning in trial

FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia

Rocket Pharmaceuticals CEO Gaurav Shah sells $7,752 in shares - Investing.com

Recursion Pharmaceuticals Stock Climbs 13% As AI Drug Pipeline Progress And Spending Cuts Boost Sentiment - TIKR.com

Eton Pharmaceuticals CEO Sean Brynjelsen sells $6.08m in stock - Investing.com

Agios Pharmaceuticals: Indication Stacking Is Creating A Commercial Flywheel (NASDAQ:AGIO) - Seeking Alpha

Teva scores rare partial win in CMS price negotiation appeal - Fierce Pharma

Vertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still Ahead - The Motley Fool

Amylyx Pharmaceuticals Announces Pricing of an Upsized $500 Million Underwritten Public Offering of Common Stock - Business Wire

Celon Pharma's generic semaglutide drug matches Ozempic in early study, shares jump - Reuters

How Investors Are Reacting To Aurinia Pharmaceuticals (AUPH) Extended Voclosporin Exclusivity And Share Buyback - Yahoo Finance

Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market - Corsicana Daily Sun

FDA Approves ENNUMO™ (pegfilgrastim-pccg), Accord BioPharma's Second Pegfilgrastim Biosimilar to NEULASTA® (pegfilgrastim) - PR Newswire

Quantum BioPharma Stock Gains 6.7% on FDA Clearance for Lucid-MS Phase 2 Trial - kalkine.ca

China A-Shares Close Higher Across All Four Major Indexes; Biopharma Sector Surges as Over 4,100 Stocks Gain - finance.biggo.com

Manor College president named to biopharmaceutical company’s board of directors - Glenside Local

Ingenia Therapeutics Debuts on KOSDAQ to Accelerate Next-Gen Vascular Antibody Pipeline - BioPharma APAC